PROPIOMAZINE FOR CONTROL OF INSOMNIA IN NERVOUS DISORDERS
Abstract
Fifty-two psychiatric patients and 4 with severe insomnia only received propiomazine orally as a hypnotic. 1. Forty milligrams proved the most satisfactory dose; smaller amounts were relatively ineffective; larger doses did not increase the hypnotic response. 2. Seventy-seven percent exhibited a good to excellent result. 3. No toxic effects or severe side reactions were observed. Propiomazine is an effective hypnotic, comparable to the new synthetic sedative agents. Further studies are recommended.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
